Health Condition 1: C13- Malignant neoplasm of hypopharynx
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Histologically proven laryngopharyngeal cancers with unilateral or bilateral fixed vocal cords confirmed with endoscopy or laryngoscopy, patients giving written informed consent to participate in the study,patients with ECOG PS 0 to 2,baseline CBC, LFT and RFT are within normal limits, at least 3 months of follow up after completion of treatment
Exclusion criteria
Exclusion criteria: Patients with vocal cord mobility impairment due to causes other than laryngopharyngeal cancers and its treatment (eg: congenital anomalies, trauma, neurological disorders), patients with laryngopharyngeal cancers with extra laryngeal extension or cartilage erosion,patient unwilling or unable to participate in follow-up assessments,patients with other concurrent head and neck cancers,patients with uncontrolled cardiovascular, pulmonary or metabolic renal disease,patient with metastatic laryngopharyngeal cancers with fixed vocal cords.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| RESTORATION OF VOCAL CORD MOBILITY AFTER DEFINITIVE CHEMO RADIATION IN LARYNGOPHARYNGEAL CANCERS WITH PREVIOUSLY FIXED VOCAL CORDS ASSESSED USING DIRECT LARYNGOSCOPY OR ENDOSCOPY AT SPECIFIC TIME INTERVALS. COMPLETE ABDUCTION OF VOCAL CORDS DEFINED AS SEPARATION OF ATLEAST 1 CM FROM MIDLINE WILL BE CONSIDERED AS INDICATOR RESTORED MOBILITY.Timepoint: At 6 weeks post definitive chemoradiation and at 3 months post definitive chemoradiation | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess for acute radiotherapy induced toxicities,to assess the voice related quality of life using Voice Handicap Index (VHI) in these group of patients. Timepoint: Acute Radiotherapy Induced toxicities will be assessed during treatment weekly. Voice Related Quality of life will be evaluated using Voice Handicap Index pre treatment, at 6 weeks post treatment and at 3 months post treatment | — |
Countries
India
Contacts
Dr Bhubaneswar Borooah Cancer Institute